Consumption of isoflavone-rich soy protein does not alter homocysteine or markers of inflammation in postmenopausal women

European Journal of Clinical Nutrition

Volumn 62, Issue 12, 2008, Pages 1419-1425

  Greany, K A ^a   Nettleton, J A ^a   Wangen, K E ^a   Thomas, W ^a   Kurzer, M S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; EQUOL; FOLIC ACID; HOMOCYSTEINE; INTERCELLULAR ADHESION MOLECULE 1; ISOFLAVONE; LIPID; METHIONINE; MILK PROTEIN; SOYBEAN PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DIET SUPPLEMENTATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; POSTMENOPAUSE; PRIMARY PREVENTION; PROTEIN BLOOD LEVEL; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; VITAMIN INTAKE;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY DISEASE; CROSS-OVER STUDIES; E-SELECTIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FASTING; FEMALE; HOMOCYSTEINE; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; ISOFLAVONES; MIDDLE AGED; MILK PROTEINS; POSTMENOPAUSE; SOYBEAN PROTEINS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 57449118471     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1602885     Document Type: Article

References (48)

1. Baum JA, Teng H, Erdman Jr JW, Weigel RM, Klein BP, Persky VW et al. (1998). Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women. Am J Clin Nutr 68, 545-551.
2. Blum A, Lang N, Peleg A, Vidger F, Israeli P, Gumanovsky M et al. (2003). Effects of oral soy protein on markers of inflammation in postmenopausal women with mild hypercholesterolemia. Am Heart J 145, e7.
3. Blum A, Schenke WH, Hathaway L, Mincemoyer R, Csako G, Waclawiw MA et al. (2000). Effects of estrogen and the selective estrogen receptor modulator raloxifene on markers of inflammation in postmenopausal women. Am J Cardiol 86, 892-895.
4. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG (1995). A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 274 1049-1057.
5. Brouwers E, L'Homme R, Al-Maharik N, Lapcik O, Hampl R, Wahala K et al. (2003). Time-resolved fluoroimmunoassay for equol in plasma and urine. J Steroid Biochem Mol Biol 84, 577-588.
6. Caulin-Glaser T, Watson CA, Pardi R, Bender JR (1996). Effects of 17 beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J Clin Invest 98, 36-42.
7. D'Anna R, Baviera G, Corrado F, Cancellieri F, Crisafulli A, Squadrito F (2005). The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women. Acta Obstet Gynecol Scand 84, 474-477.
8. de Valk-de Roo G, Stehouwer C, Meijer P, Mijatovic V, Kluft C, Kenemans P et al. (1999). Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women. Arterioscler Thromb Vasc Biol 19, 2993-3000.
9. FDA (1999). Food and Drug Administration final rule: Food labeling health claims; soy protein and coronary heart disease. Fed Regist 64, 57699-57733.
10. Greany KA, Nettleton JA, Wangen KE, Thomas W, Kurzer MS (2004). Probiotic consumption does not enhance the cholesterol-lowering effect of soy in postmenopausal women. J Nutr 134, 3277-3283.
11. Gruber C, Tshugguel W, Schneeberger C, Huber J (2002). Production and actions of estrogens. N Engl J Med 346, 340-351.
12. Hall W, Vafeiadou K, Bugel S, Koebnick C, Reimann M, Ferrari M et al. (2005). Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: Interactions with genotype and equol production. Am J Clin Nutr 82, 1260-1268.
13. Hanson LN, Engelman HM, Alekel DL, Schalinske KL, Kohut ML, Reddy MB (2006). Effects of soy isoflavones and phytate on homocysteine, C-reactive protein, and iron status in postmenopausal women. Am J Clin Nutr 84, 774-780.
14. Hilpert KF, Kris-Etheron P, West CE (2005). Lipid response to a low-fat diet with or without soy is modified by C-reactive protein status in moderately hypercholesterolemic adults. J Nutr 135, 1075-1079.
15. Hwang SJ, Ballantyne CM, Sharret AR, Smith LC, Davis CE, Gotto AM et al. (1997). Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases. Circulation 96, 4219-4225.
16. Jenkins DJ, Kendall CW, Connelly PW, Jackson CJ, Parker T, Faulkner D et al. (2002a). Effects of high- and low-isoflavone (phytoestrogen) soy foods on inflammatory biomarkers and proinflammatory cytokines in middle-aged men and women. Metabolism 51, 919-924.
17. Jenkins DJ, Kendall CW, Jackson CJ, Connelly PW, Parker T, Faulkner D et al. (2002b). Effects of high and low isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr 76, 365-372.
18. Jenkins DJ, Kendall CW, Marchie A, Faulkner D, Wong J, de Souza R et al. (2003). Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA 290, 502-510.
19. Koh KK, Cardillo C, Bui MN, Hathaway L, Csako G, Waclawiw MA et al. (1999). Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women. Circulation 99, 354-360.
20. Lampe JW, Karr SC, Hutchins AM, Slavin JL (1998). Urinary soy excretion with a soy challenge: Influence of habitual diet. Proc Soc Exp Biol Med 217, 335-339.
21. L'Homme R, Brouwers E, Al-Maharik N, Lapcik O, Hampl R, Mikola H et al. (2002). Time-resolved fluoroimmunoassay of plasma and urine O-desmethylangolensin. J Steroid Biochem Mol Biol 81, 153-157.
22. 2 cells. J Nutr 130, 2543-2549.
23. Nettleton JA, Greany KA, Thomas W, Wangen KE, Adlercretuz H, Kurzer MS (2004). Plasma phytoestrogens are not altered by probiotic consumption in postmenopausal women with and without a history of breast cancer. J Nutr 134, 1998-2003.
24. Nettleton JA, Greany KA, Thomas W, Wangen KE, Adlercretuz H, Kurzer MS (2005). Short-term soy and probiotic supplementation does not markedly affect concentrations of reproductive hormones in postmenopausal women with and without histories of breast cancer. J Alt Comp Med 11 1067-1074.
25. Nikander E, Metsa-Heikkila M, Tiitinen A, Ylikorkala O (2003). Evidence of a lack of effect of a phytoestrogen regimen on the levels of C-reactive protein, e-selectin, and nitrate in postmenopausal women. J Clin Endocrinol Metab 88, 5180-5185.
26. Olszewski AJ, McCully KS (1991). Homocysteine content of lipoproteins in hypercholesterolemia. Atherosclerosis 88, 61-68.
27. Puska P, Korpelainen V, Hoie LH, Skovlund E, Lahti T, Smerud KT (2002). Soy in hypercholesterolaemia: A double-blind, placebo-controlled trial. Eur J Clin Nutr 56, 352-357.
28. Register T, Cann J, Kaplan J, Williams J, Adams M, Morgan T et al. (2005). Effects of soy isoflavones and conjugated equine estrogens on inflammatory markers in atherosclerotic, ovariectomized monkeys. J Clin Endocrinol Metab 90, 1734-1740.
29. Reimann M, Dierkes J, Carlson A, Talbot D, Ferrari M, Hallund J et al. (2006). Consumption of soy isoflavones does not affect plasma total homocysteine or asymmetric dimethylarginine concentrations in healthy postmenopausal women. J Nutr 136, 100-105.
30. Ridker PM, Buring J, Shih JC, Matias M, Hennekens C (1998). Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98, 731-733.
31. Ridker PM, Hennekens C, Buring J, Rifai N (2000). C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342, 836-843.
32. Ridker PM, Manson JE, Buring JE, Shih J, Matias M, Hennekens CH (1999). Homocysteine and risk of cardiovascular disease among postmenopausal women. JAMA 281, 1817-1821.
33. Roughead Z, Hunt J, Johnson J, Badger T, Lykken G (2005). Controlled substitution of soy protein for meat protein: Effects on calcium retention, bone, and cardiovascular health indices in postmenopausal women. J Clin Endocrinol Metab 90, 181-189.
34. Ryan-Borchers TA, Park JS, Chew BP, McGuire MK, Fournier LR, Beerman KA (2006). Soy isoflavones modulate immune function in healthy postmenopausal women. Am J Clin Nutr 83, 1118-1125.
35. Setchell K, Brown N, Lydeking-Olsen E (2002). The clinical importance of the metabolite equol - a clue to the effectiveness of soy and its isoflavones. J Nutr 132, 3577-3584.
36. Skouby SO, Gram J, Andersen LF, Sidelmann J, Petersen KR, Jespersen J (2002). Hormone replacement therapy: Estrogen and progestin effects on plasma C-reactive protein concentrations. Am J Obstet Gynecol 186, 969-977.
37. Steinberg F, Guthrie N, Villablanca AC, Kumar K, Murray M (2003). Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women. Am J Clin Nutr 78, 123-130.
38. Teede HJ, Dalais FS, McGrath BP (2004). Dietary soy containing phytoestrogens does not have detectable estrogenic effects on hepatic protein synthesis in postmenopausal women. Am J Clin Nutr 79 396-401.
39. Teede HJ, McGrath BP, Lakmini D, Cehun M, Fassoulakis A, Nestel P (2003). Isoflavones reduce arterial stiffness: A placebo-controlled study in men and postmenopausal women. Arterioscler Thromb Vasc Biol 23, 1066-1071.
40. Tonstad S, Smerud K, Hoie L (2002). A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects. Am J Clin Nutr 76, 78-84.
41. Walsh BW, Cox DA, Sashegyi A, Dean RA, Tracy RP, Anderson PW (2001). Role of tumor necrosis factor-alpha and interleukin-6 in the effects of hormone replacement therapy and raloxifene on C-reactive protein in postmenopausal women. Am J Cardiol 88, 825-828.
42. Walsh BW, Paul S, Wild R, Dean RA, Tracy RP, Cox DA et al. (2000). The effects of hormone replacement therapy and raloxifene on Creactive protein and homocysteine in healthy postmenopausal women: A randomized controlled trial. J Clin Endocrinol Metab 85, 214-218.
43. Wang G, Lapcik O, Hampl R, Uehara M, Al-Maharik N, Stumpf K et al. (2000). Time-resolved fluoroimmunoassay of plasma daidzein and genistein. Steroids 65, 339-348.
44. West SG, Hilpert KF, Juturu V, Bordi PL, Lampe JW, Mousa SA et al. (2005). Effects of including soy protein in a blood cholesterol-lowering diet on markers on cardiac risk in men and in postmenopausal women with and without hormone replacement therapy. J Womens Health 14, 253-262.
45. Xu X, Duncan AM, Wangen KE, Kurzer MS (2000). Soy consumption alters endogenous estrogen metabolism in postmenopausal women. J Nutr 9, 781-786.
46. Yildirir A, Aybar F, Tokgozoglu L, Yarali H, Kabakci G, Bukulmez O et al. (2002). Effects of hormone replacement therapy on plasma homocysteine and C-reactive protein levels. Gynecol Obstet Invest 53, 54-58.
47. Yildiz MF, Kumru S, Godekmerdan A, Kutlu S (2005). Effects of raloxifene, hormone therapy, and soy isoflavone on serum high-sensitive C-reactive protein in postmenopausal women. Int J Gynaecol Obstet 90, 128-133.
48. Zhang SX, Shu X, Gao YT, Yang G, Li Q, Li H et al. (2003). Soy food consumption is associated with lower risk of coronary heart disease in Chinese women. J Nutr 133, 2874-2878.